2009

Stordal, Britta and Davey, Ross (2009) A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1. Current Cancer Drug Targets, 9 (3). pp. 354-365. ISSN 1568-0096

Stordal, Britta and Davey, Ross (2009) ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair. Cancer Chemotherapy and Pharmacology, 63 (4). pp. 661-672. ISSN 1432-0843

Stordal, Britta and Davey, Ross (2009) Regrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrest. In: Bonetti, Andrea, Leone, Roberto, Muggia, Franco and Howell, Stephen, (eds.) Platinum and other heavy metal compounds in cancer chemotherapy. Cancer drug discovery and development . Humana Press, pp. 171-176. ISBN 978-1-60327-459-3

Stordal, Britta, Pavlakis, Nick and Davey, Ross (2009) Treating cisplatin-resistant cancer: a systematic analysis of oxaliplatin or paclitaxel salvage chemotherapy. In: Bonetti, Andrea, Leone, Roberto, Muggia, Franco and Howell, Stephen, (eds.) Platinum and other heavy metal compounds in cance chemotherapy. Cancer drug discovery and development . Humana Press. ISBN 978-1-60327-459-3

2007

Stordal, Britta, Pavlakis, Nick and Davey, Ross (2007) A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship. Cancer Treatment Reviews, 33 (8). pp. 688-703. ISSN 0305-7372

Stordal, Britta, Pavlakis, Nick and Davey, Ross (2007) Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review. Cancer Treatment Reviews, 33 (4). pp. 347-357. ISSN 0305-7372

2006

Stordal, Britta, Davey, Mary W. and Davey, Ross (2006) Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Cancer Chemotherapy and Pharmacology, 58 (2). pp. 256-265. ISSN 0344-5704